Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
Detailled Reference
Request a copy
Article (Scientific journals)
Neprilysin Inhibitors and Angiotensin(1-7) in COVID-19.
Esser, Nathalie
;
Zraika, Sakeneh
2020
•
In
British Journal of Cardiology, 27
(4), p. 109-111
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/267277
DOI
10.5837/bjc.2020.031
PubMed
33795925
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
Esser-AS-TD-TA.pdf
Author preprint (120.51 kB)
Request a copy
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Keywords :
COVID-19; angiotensin(1-7); coronavirus; neprilysin; renin-angiotensin system
Disciplines :
Immunology & infectious disease
Author, co-author :
Esser, Nathalie
;
University of Washington - UW > Department of Medicine > Division of Metabolism, Endocrinology and Nutrition
Zraika, Sakeneh;
University of Washington - UW > Department of Medicine > Division of Metabolism, Endocrinology and Nutrition
Language :
English
Title :
Neprilysin Inhibitors and Angiotensin(1-7) in COVID-19.
Publication date :
2020
Journal title :
British Journal of Cardiology
ISSN :
0969-6113
eISSN :
1753-4313
Volume :
27
Issue :
4
Pages :
109-111
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 18 January 2022
Statistics
Number of views
57 (4 by ULiège)
Number of downloads
2 (2 by ULiège)
More statistics
OpenCitations
0
OpenAlex citations
7
Bibliography
Similar publications
Contact ORBi